International Activities

Lanco Medical Group Facilitates Access to FDA-Approved Primer Treatment for Nasopharyngeal Carcinoma in Central America.

The announcement of  TopAlliance Biosciences, a wholly-owned subsidiary of Junshi Biosciences of FDA approval of LOQTORZI™ (toripalimab-tpzi), marks a success in the treatment of nasopharyngeal carcinoma (NPC). This treatment, the first and only FDA approved for this condition, will now be available in Central America thanks to Lanco Medical Group’s robust platform and regional presence, ensuring this vital treatment is no longer needed. TopAlliance Biosciences trusted Lanco Medical Gro...
Read More

Lanco Medical Group and Aurobindo Forge a Powerful Alliance to Enhance Healthcare Solutions

In a significant stride toward advancing healthcare solutions, Lanco Medical Group and Aurobindo, two stalwarts in the medical industry, have joined forces in a groundbreaking partnership. This strategic alliance aims to revolutionize the healthcare landscape, bringing innovative treatments, cutting-edge technologies, and enhanced patient care to the forefront. Lanco Medical Group, renowned for its commitment to comprehensive healthcare and patient-centric services, has partnered with Aurobindo,...
Read More

In 2022, Lanco Medical Group embarked on an extraordinary journey by forming a strategic alliance with Nobel Pharmaceuticals

Today, we are thrilled to share the latest milestone in our partnership – the launch of groundbreaking cardiovascular and cardiometabolic products across Central America!  Innovation That Inspires: Nobel Pharmaceuticals, a global healthcare leader, brings over half a century of innovation and excellence to our region. Their commitment to R&D has earned them a top spot among companies investing in groundbreaking research.  A Shared Vision: At Lanco Medical Group, we share Nobel’s vi...
Read More

Venipharm and Lanco Medical Group Announce Strategic Partnership to Expand Market Reach into Central America and Mexico

– Venipharm,a leading French pharmaceutical company specializing in generics and pharmaceutical development, has announced a groundbreaking strategic partnership with Lanco Medical Group, a renowned player in the pharmaceutical industry based in the United States. This innovative collaboration aims to extend the reach of high-quality pharmaceutical solutions to Central America and Mexico. Venipharm, known for its dedication to providing high-quality pharmaceutical solutions, has established i...
Read More

Transforming Healthcare Together: Elevating Healthcare Standards in Central America Through Our Strategic Alliance with Zydus Lifesciences

We are thrilled to announce a groundbreaking partnership that is reshaping the landscape of healthcare in Central America. Through our strategic alliance with Zydus Lifesciences, we are introducing top-tier therapies to the region, revolutionizing the way healthcare is delivered. Together, we are not just providing treatments; we are making a significant and positive impact on the overall healthcare scenario in Central America....
Read More

Celebrating 30 years of the Diplomatic Association of Panama

A night of elegance and commitment. Celebrating 30 years of the Diplomatic Association of Panama in collaboration with Lanco Medical Group. Honoring the charitable work of the ADP and its 'Light for Education' program. Classical music at the Balboa Theater united diplomats, authorities and the community to support a noble cause....
Read More

Lanco Medical Group was present at the FIME 2023 – USA

Through our Medical Supply subsidiary Alcala Pharma, we attended this event where we held strategic meetings with the most important suppliers in Asia, Europe and the United States....
Read More

Lanco Medical Group expressed their interest in executing projects in The Salvador

Recently, representatives of Lanco Medical Group, a Colombian pharmaceutical company, expressed their interest in executing projects in the country due to the decrease in crime rates and the increase in security....
Read More
en_US